The C1 Esterase Inhibit0r for Inject, cataloged under National Stock Number 6505-01-666-8073, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Csl Behring L.l.c. Dba Csl Behring Llc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: EA.
| Parameter | Value |
|---|---|
| NSN | 6505-01-666-8073 |
| Primary Part Number | NDC63833-0829-02 |
| Item Name | C1 Esterase Inhibit0r for Inject |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Csl Behring L.l.c. Dba Csl Behring Llc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | EA |
| Part Number | Manufacturer |
|---|---|
| NDC63833-0829-02 PRIMARY | Csl Behring L.l.c. Dba Csl Behring Llc (USA) |
| Reference | Meaning |
|---|---|
| 1488773 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM173833 | 5/1 Secondary reference Defense Medical Standardization Board |
| HAEGARDA | 3/1 Design control — primary reference Csl Behring L.l.c. Dba Csl Behring Llc |
NSN 6505-01-666-8073 is a C1 Esterase Inhibit0r for Inject, manufactured by Csl Behring L.l.c. Dba Csl Behring Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-666-8073 has 1 manufacturer part number on file: NDC63833-0829-02 (Csl Behring L.l.c. Dba Csl Behring Llc).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-667-5382. Verify interchangeability with system specifications before substitution.
Key specifications for NDC63833-0829-02: Special Features: C1 ESTERASE INHIBITOR FOR INJECTION, PLASMA-DERIVED CONCENTRATE OF C1 ESTERASE INHIBITOR (HUMAN) (C1-INH) WHITE LYOPHILIZED POWDER SUPPLIED IN SINGLE-USE VIALS CONTAINING 3000 INTERNATIONAL UNITS (IU) OF C1-INH PACKAGED WITH STERILE WATER FOR INJECTION, USP (6 ML OF STERILE WATER FOR INJECTION, USP PROVIDED FOR RECONSTITUTION OF 3000 IU ALONG WITH ONE MIX2VIAL FILTER TRANSFER SET. NOT MADE WITH NATURAL RUBBER LATEX; PRESERVATIVE FREE; 3000 IU HAEGARDA VIAL CONTAINS C1-INH AS A LYOPHILIZED CONCENTRATE FOR RECONSTITUTION INDICATED FOR ROUTINE PROPHYLAXIS TO PREVENT HEREDITARY ANGIOEDEMA (HAE) ATTACKS IN ADOLESCENT AND ADULT PATIENTS; ADMINISTER AT ROOM TEMPERATURE WITHIN 8 HOURS AFTER RECONSTITUTION. DISCARD PARTIALLY USED VIALS. DO NOT FREEZE THE RECONSITUTED SOLUTION; PROTECT FROM LIGHT; STORE AT 30 C (86 F); Part Name Assigned by Controlling Agency: HAEGARDA, 3000 I.U. SINGLE USE VIAL, W/ DILUENT. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.